Tech Company Financing Transactions

iECURE Funding Round

On 11/30/2022, iECURE announced $65 million in Series A funding from Lyfe Capital, Novo Holdings and OrbiMed.

Transaction Overview

Company Name
iECURE
Announced On
11/30/2022
Transaction Type
Venture Equity
Amount
$65,000,000
Round
Series A
Investors

Lyfe Capital (Lead Investor)

Novo Holdings (Lead Investor)

OrbiMed (Stephen Squinto)

Versant Ventures (Thomas Woiwode)

Proceeds Purpose
The company intends to use the funds to execute all the tasks necessary to begin clinical development of what could be the mutation-agnostic in vivo gene insertion therapeutic program.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Philadelphia, PA 19019
USA
Phone
(217) 817-4800
Website
www.iecure.com
Email Address
[email protected]
Overview
We are a mutation-agnostic in vivo gene insertion company striving to cure liver disorders with high unmet need by harnessing new advancements in genetic medicine. Our in vivo insertion methods knock-in healthy copies of disease-causing genes, offering long-term, stable expression of those genes in patients.
Profile
iECURE LinkedIn Company Profile
Social Media
iECURE Company Twitter Account
Company News
iECURE News
Facebook
iECURE on Facebook
YouTube
iECURE on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Joseph Truitt
  Joseph Truitt LinkedIn Profile  Joseph Truitt Twitter Account  Joseph Truitt News  Joseph Truitt on Facebook
Chief Operating Officer
Paul Firuta
  Paul Firuta LinkedIn Profile  Paul Firuta Twitter Account  Paul Firuta News  Paul Firuta on Facebook
VP - Bus. Development
Alex Monteith
  Alex Monteith LinkedIn Profile  Alex Monteith Twitter Account  Alex Monteith News  Alex Monteith on Facebook

 

 

Browse more venture capital transactions:

Prev: 11/30/2022: Sphere Technology Solutions venture capital transaction
Next: 11/30/2022: Dwarfs venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

Our team works diligently to record every notable VC transaction. VC transactions reported here come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.